Results 251 to 260 of about 58,438 (289)

TMS-19-Q・GC錠による化膿性皮膚疾患の治療

open access: yesTMS-19-Q・GC錠による化膿性皮膚疾患の治療
openaire  

小児感染症に対するTMS-19-Q DS 200の臨床的検討

open access: yes小児感染症に対するTMS-19-Q DS 200の臨床的検討
openaire  

[Clinical studies on TMS-19-Q.O tablet in respiratory tract infection].

The Japanese journal of antibiotics, 1985
A new macrolide antibiotic preparation, TMS-19-Q.O tablet, was used to investigate the efficacy in the treatment of patients with respiratory tract infection, and the results obtained were as follows: Three hundred and seven cases were included in this report, and overall efficacy rate was 76.2%.
K, Hara   +9 more
openaire   +1 more source

[Clinical evaluation of TMS-19-Q, a new macrolide antibiotic, in otorhinolaryngological infections].

The Japanese journal of antibiotics, 1985
The clinical study for TMS-19-Q.O tablet was performed with multicenter trial. The results obtained were as follows; Final global improvement rating in 332 cases of otorhinolaryngological infections were excellent in 99, good in 142, fair in 40 and poor in 51 and the effective rate was 72.6%. Those of 266 cases with acute infection were excellent in 93
S, Baba   +9 more
openaire   +1 more source

[Clinical and bacteriological evaluation of TMS-19-Q in superficial suppurative skin and soft tissue infection].

The Japanese journal of antibiotics, 1985
Clinical effectiveness of TMS-19-Q, a new macrolide antibiotic, was evaluated in superficial infectious diseases classified into 6 groups at 13 departments of dermatology. The results obtained were as follows: Final global improvement rating in 311 cases were excellent in 91, good in 158, fair in 45 and poor in 17 and the effective rate was 80.1 ...
S, Watanabe   +9 more
openaire   +1 more source

[Clinical studies on TMS-19-Q.O tablets, the preparation of a new macrolide antibiotic, in the field of oral surgery].

The Japanese journal of antibiotics, 1985
Multicenter clinical trial or TMS-19-Q.O tablet was performed to evaluate the usefulness in oral surgery. The results obtained were as follows: Clinical efficacy was assessed by clinical points. The patients entered into the trial were 77 cases with periodontitis, 23 with pericoronitis, 92 with osteitis of jaw and 18 with other infections, and the each
J, Sasaki   +9 more
openaire   +1 more source

[Clinical evaluation of the TMS-19-Q.GC tablet in acute tonsillitis. A comparative double blind study with josamycin].

The Japanese journal of antibiotics, 1985
In order to compare the clinical efficacy and safety of TMS-19-Q.GC tablet (TMS) with josamycin tablet (JM) in acute tonsillitis, the double blind trial was carried out with the daily dosage of 200 mg X 3 in TMS and 400 mg X 3 in JM. Number of cases evaluated for clinical efficacy were 154 cases (73 treated with TMS and 81 treated with JM).
S, Baba   +9 more
openaire   +1 more source

Home - About - Disclaimer - Privacy